RxSight price target lowered to $44 from $58 at BTIG
BTIG lowered the firm’s price target on RxSight (RXST) to $44 from $58 and keeps a Buy rating on the shares after its in-line Q4 results. The ...
Masimo price target raised to $206 from $178 at BTIG
BTIG analyst Marie Thibault raised the firm’s price target on Masimo (MASI) to $206 from $178 and keeps a Buy rating on the shares after its Q4 ...
S&P 500's technical set-up suggests a short-term bounce, says BTIG's Krinsky
The S&P 500's latest sell-off took it back to its February lows of 5923, notes Jonathan Krinsky, BTIG's technical guru. That's left it in danger of breaking below the uptrend from last summer's low.
Stocks could see near-term bounce, but don't be fooled: BTIG's Krinsky
The S&P 500 may be due for a short-term bounce after its pullback from last week's record highs — but don't expect it to last ...
Trump's tariffs could make international stocks more attractive than U.S. investments. Here's why.
Indeed, one major draw of international stocks is that they look much cheaper compared with their U.S. counterparts. The S&P 500 traded at 22 times forward earnings as of Tuesday, while the STOXX 600 ...
Investing15d
BTIG maintains Neutral on Kilroy Realty shares post-earnings
On Tuesday, BTIG analyst Thomas Catherwood maintained a Neutral rating on shares of Kilroy Realty Corporation (NYSE:KRC), following the company's release of its fourth-quarter 2024 financial results.
Investing15d
BTIG starts ARMOUR Residential stock with neutral rating
On Monday, BTIG initiated coverage on ARMOUR Residential (NYSE:ARR) with a Neutral rating. The firm's analysis suggests a potential for a 20%+ total return, factoring in a steady 15% dividend yield ...
Investing15d
BTIG maintains neutral on Global Payments ahead of earnings
On Monday, BTIG analyst Andrew Harte maintained a Neutral rating on Global Payments Inc. (NYSE:GPN) stock, despite an approximate 11% increase in share value since the company's third-quarter 2024 ...